Medicare Enrolled
Dr. Daniel Oberlin, M.D.
Urology Physician · Berkeley, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Oberlin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oberlin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Oberlin
Dr. Daniel Oberlin is an urology physician in Berkeley, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Oberlin performed 2,084 Medicare services across 1,441 unique beneficiaries.
Between the years covered by Open Payments, Dr. Oberlin received a total of $48,720 from 53 pharmaceutical and/or device companies across 344 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Oberlin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 38% volume in CA
$48,720 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,084
Medicare services
Top 38% in CA for urology physician
1,441
Unique beneficiaries
$121
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~149 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
564 | $108 | $305 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
414 | $74 | $216 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
100 | $0 | $1 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
98 | $4 | $9 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
94 | $136 | $391 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 93 | $136 | $500 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
84 | $48 | $122 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
71 | $73 | $195 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
64 | $242 | $635 |
| Simple change of bladder tube | 63 | $96 | $243 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
63 | $941 | $2,458 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
63 | $52 | $137 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
51 | $146 | $426 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
42 | $13 | $33 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
41 | $35 | $86 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
40 | $14 | $36 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
34 | $144 | $369 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
25 | $57 | $200 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
18 | $57 | $158 |
| Complicated insertion of bladder tube | 16 | $144 | $377 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
13 | $1,352 | $3,513 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
11 | $112 | $604 |
| New patient office visit, complex (60-74 min) | 11 | $200 | $516 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
11 | $105 | $229 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$48,720
Total received (2018-2024)
Avg $6,960/year across 7 years
Top 7% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
344
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$31,219 (64.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,678 (21.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,823 (14.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,896
2023
$1,265
2022
$1,551
2021
$7,966
2020
$18,564
2019
$8,836
2018
$642
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$8,711
Sumitomo Pharma America, Inc.
$188
ACCORD HEALTHCARE, INC.
$177
ABBVIE INC.
$156
Janssen Biotech, Inc.
$132
Astellas Pharma US Inc
$75
Merck Sharp & Dohme LLC
$62
PFIZER INC.
$60
PROCEPT BioRobotics Corporation
$43
Dendreon Pharmaceuticals LLC
$34
IMMUNITYBIO, INC.
$32
Myriad Genetic Laboratories, Inc.
$30
BLUEWIND MEDICAL
$27
Photocure Inc
$27
C. R. Bard, Inc. & Subsidiaries
$27
Telix Pharmaceuticals
$26
UROGEN PHARMA, INC.
$25
Verity Pharmaceuticals Inc.
$23
COLOPLAST CORP
$22
Boston Scientific Corporation
$17
Top 3 companies account for 91.7% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$20,456
NeoTract Inc.
$8,899
INTUITIVE SURGICAL, INC.
$8,711
Teleflex LLC
$2,747
Janssen Biotech, Inc.
$1,638
Astellas Pharma US Inc
$1,084
PROCEPT BioRobotics Corporation
$407
Sumitomo Pharma America, Inc.
$367
Dendreon Pharmaceuticals LLC
$356
Calyxo, Inc.
$350
ABBVIE INC.
$316
Endo Pharmaceuticals Inc.
$304
Amgen Inc.
$279
Boston Scientific Corporation
$274
PFIZER INC.
$255
ACCORD HEALTHCARE, INC.
$195
AbbVie, Inc.
$172
AbbVie Inc.
$147
Blue Earth Diagnostics Limited
$144
Merck Sharp & Dohme LLC
$122
Bayer HealthCare Pharmaceuticals Inc.
$117
Myovant Sciences Inc.
$115
Myriad Genetic Laboratories, Inc.
$107
CONMED Corporation
$99
Janssen Scientific Affairs, LLC
$94
Bard Access Systems, Inc.
$90
UroGen Pharma, Inc.
$85
Agiliti Surgical, Inc.
$61
Sun Pharmaceutical Industries Inc.
$59
UROVANT SCIENCES INC
$58
Olympus America Inc.
$53
AngioDynamics, Inc.
$43
KARL STORZ Endoscopy-America
$37
IMMUNITYBIO, INC.
$32
Allergan, Inc.
$32
Tolmar, Inc.
$29
Acerus Pharmaceuticals Corporation
$28
BLUEWIND MEDICAL
$27
Photocure Inc
$27
C. R. Bard, Inc. & Subsidiaries
$27
Telix Pharmaceuticals
$26
UROGEN PHARMA, INC.
$25
Accord Healthcare, Inc.
$24
Verity Pharmaceuticals Inc.
$23
Progenics Pharmaceuticals, Inc.
$23
Avadel Specialty Pharmaceuticals, LLC
$22
COLOPLAST CORP
$22
Ferring Pharmaceuticals Inc.
$21
Hollister Incorporated
$21
Laborie Medical Technologies Corp.
$19
Coloplast Corp
$19
TOLMAR Pharmaceuticals, Inc.
$18
Allergan Inc.
$13
Top 3 companies account for 78.1% of all-time payments
Associated products mentioned in payments ›
AIRSEAL · AMS · ANKTIVA · AQUABEAM SYSTEM · AVEED · AirSeal · AquaBeam Robotic System · Axumin · BOTOX · Bard Urinary Drainage Bag · CAMCEVI · CVAC · CYSVIEW · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLEX-XC CMOS URETEROSCOPE 8.5 FR X 675MM · GEMTESA · GENERAL - BPH · GENERAL BPH · GreenLight XPS · ILLUCCIX · Infyna Chic · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LithoVue · Luja Coude · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NANOKNIFE · Natesto · Noctiva · Nubeqa · ORGOVYX · Olympus Laser Devices · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · REVI · SPACEOAR · Titan · Trelstar · UROLIFT · UROLIFT SYSTEM · UroLift · UroLift System · Veozah · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for urology physician in CA.
Geographic Context
Urology physicians within 10 mi
149
Per 100K population
9.0
County median income
$126,240
Nearest hospital
ALTA BATES SUMMIT MEDICAL CENTER - ALTA BATES CAMP
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Oberlin is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 7% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Oberlin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Oberlin performed 564 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Oberlin receive payments from pharmaceutical companies?
Yes. Dr. Oberlin received a total of $48,720 from 53 companies across 344 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oberlin's costs compare to other urology physicians in Berkeley?
Dr. Oberlin's average Medicare payment per service is $121. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oberlin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Berkeley
Browse urology physicians in Berkeley ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology